Herpes Zoster for Primary Care: An Evidence-based Approach to Adult Immunization
Clinical Update
  • Home
  • Herpes Zoster for Primary Care: An Evidence-based Approach to Adult Immunization (Full program)
  • Introduction: From VZV to HZ
  • The Burden of HZ
  • Focus on Post-herpetic Neuralgia (PHN)
  • Focus on Herpes Zoster Ophthalmicus (HZO)
  • Is HZ a Risk Factor for Stroke?
  • Prevention of HZ and Complications - Live Attenuated HZ Vaccine
    (Full Chapter)
  • Clinical Trial Data
  • Practical Measures: NNV,
    Cost-effectiveness and
    Duration of Protection
  • Real-world Effectiveness
  • Prevention of HZ and Complications – Non-live Adjuvanted Two-dose Vaccine: Clinical Trial Data
  • NACI Recommendations and Relaying the Rationale for Vaccination to Patients
  • Risk-based Approach to HZ Vaccination: Emerging Risk Factors for HZ
  • Summary and Conclusions
  • Supplementary Slides: NACI 2014 Update on the Use of HZ Vaccine
MRK 160 Banner
Marla Shapiro, C.M., MDCM, CCFP, MHSc, FRCPC, FCFP, NCMP
Professor, Department of Family and Community Medicine,
University of Toronto

Learning Objectives
After completing this program, participants will be able to:
  • Recognize the pathogenesis and clinical consequences of pain caused by
    herpes zoster (HZ)
  • Describe the burden and epidemiology of HZ and associated postherpetic neuralgia (PHN)
  • Summarize complications related to HZ including ophthalmic zoster and stroke
  • Identify patients who are at risk for HZ and in whom immunization should be considered
  • Answer questions from patients and their families about the efficacy and safety
    of the HZ vaccine
Made possible through the financial support of Merck Canada Inc. The opinions expressed herein are those of its author and do not necessarily reflect the views and opinions of Merck Canada Inc.
The information and opinions contained herein reflect the views and experience of the author and not necessarily those of the sponsor or STA Communications Inc. It is recommended that physicians evaluate their patient’s individual conditions before making a diagnosis or treatment decision. Any products mentioned herein should be used in accordance with the prescribing information contained in their respective product monographs. The content on this site is intended for health professionals. Copyright 2019 STA Communications Inc. All rights reserved. Content on this site may not be reproduced without explicit consent from the sponsor and STA Communications Inc. Terms and Conditions | Privacy Policy